TGN-1412 and BIA-2474 Trials with Tragic End: Lessons Learnt To Make Clinical Trials Safer

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|13|4|252-256

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.13, Iss.4, 2018-12, pp. : 252-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The return of the prodigal son and the extraordinary development route of antibody TGN1412 ‐ lessons for drug development and clinical pharmacology

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 4, 2015-04 ,pp. : 545-547

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical trials and surrogate end points: lessons from the ENHANCE trial

By Farmer John Alan  

Future Lipidology, Vol. 3, Iss. 4, 2008-08 ,pp. : 353-357

Future Medicine

Access to resources Recommend Favorite

Lessons for the monitoring of safety in clinical trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 148-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Trials

By  

Pancreatology, Vol. 6, Iss. 6, 2007-03 ,pp. : 510-511

Karger

Access to resources Recommend Favorite

Clinical Trials in Elderly Ovarian Cancer Patients – Does It Make Sense?

By  

Oncology Research and Treatment, Vol. 35, Iss. 3, 2012-02 ,pp. : 73-74

Karger

Access to resources Recommend Favorite